CY1109050T1 - Μεθοδος σταθεροποιησης πρωτεϊνων σε συμπλοκα μιγματα κατα την αποθηκευση τους σε υδατικους διαλυτες - Google Patents

Μεθοδος σταθεροποιησης πρωτεϊνων σε συμπλοκα μιγματα κατα την αποθηκευση τους σε υδατικους διαλυτες

Info

Publication number
CY1109050T1
CY1109050T1 CY20091100502T CY091100502T CY1109050T1 CY 1109050 T1 CY1109050 T1 CY 1109050T1 CY 20091100502 T CY20091100502 T CY 20091100502T CY 091100502 T CY091100502 T CY 091100502T CY 1109050 T1 CY1109050 T1 CY 1109050T1
Authority
CY
Cyprus
Prior art keywords
aquatic
solvents
storage
compound mixes
stabilizing proteins
Prior art date
Application number
CY20091100502T
Other languages
English (en)
Inventor
Franz-Josef Rubroeder
Reinhold Keller
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of CY1109050T1 publication Critical patent/CY1109050T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Η παρούσα εφεύρεση αφορά μια μέθοδο αποθήκευσης πρωτεϊνών σε υδατικό διαλύτη. Η προσθήκη κυστεΐνης καθυστερεί τη μείωση της δραστικής συγκέντρωσης πρωτεΐνης. Η μέθοδος είναι κατάλληλη για εφαρμογή κατά την παραγωγή πρωτεϊνών σε μικροοργανισμούς.
CY20091100502T 1999-07-02 2009-05-11 Μεθοδος σταθεροποιησης πρωτεϊνων σε συμπλοκα μιγματα κατα την αποθηκευση τους σε υδατικους διαλυτες CY1109050T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19930676A DE19930676B4 (de) 1999-07-02 1999-07-02 Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
EP00943838A EP1196447B1 (de) 1999-07-02 2000-06-20 Verfahren zur stabilisierung von proteinen in komplexen mischungen bei deren lagerung in wässrigen lösungsmitteln

Publications (1)

Publication Number Publication Date
CY1109050T1 true CY1109050T1 (el) 2014-07-02

Family

ID=7913515

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20091100502T CY1109050T1 (el) 1999-07-02 2009-05-11 Μεθοδος σταθεροποιησης πρωτεϊνων σε συμπλοκα μιγματα κατα την αποθηκευση τους σε υδατικους διαλυτες

Country Status (25)

Country Link
US (3) US6339061B1 (el)
EP (1) EP1196447B1 (el)
JP (1) JP4555525B2 (el)
KR (1) KR100754235B1 (el)
CN (1) CN1220703C (el)
AR (1) AR024621A1 (el)
AT (1) ATE423137T1 (el)
AU (1) AU768443B2 (el)
BR (1) BRPI0012150B8 (el)
CA (1) CA2377794C (el)
CY (1) CY1109050T1 (el)
DE (2) DE19930676B4 (el)
DK (1) DK1196447T3 (el)
ES (1) ES2321373T3 (el)
HK (1) HK1047115B (el)
HU (1) HU228936B1 (el)
IL (2) IL147250A0 (el)
MX (1) MXPA01012836A (el)
NO (1) NO329429B1 (el)
NZ (1) NZ516372A (el)
PL (1) PL200145B1 (el)
PT (1) PT1196447E (el)
SI (1) SI1196447T1 (el)
WO (1) WO2001002435A1 (el)
ZA (1) ZA200110507B (el)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10224111A1 (de) * 2002-05-29 2003-12-18 November Ag Molekulare Medizin Verfahren zum Assemblieren von Untereinheiten zu Kapsoiden
US20060201877A1 (en) * 2005-03-10 2006-09-14 Baldridge John W Septic system cleaning
US8116073B2 (en) * 2010-01-26 2012-02-14 Amtek System Co., Ltd. Display structure of slip-cover-hinge electronic device
CN108404194A (zh) * 2018-04-20 2018-08-17 朱清 一种快速止血纱布的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4371523A (en) * 1980-12-29 1983-02-01 The Regents Of The University Of California Reducing the aggregation of insulin in solution
FI78616C (fi) * 1982-02-05 1989-09-11 Novo Industri As Foerfarande foer framstaellning av en foer infusionsaendamaol avsedd stabiliserad insulinloesning, som har en foerhoejd zinkhalt.
DE3583880D1 (de) * 1984-04-09 1991-10-02 Takeda Chemical Industries Ltd Stabile interleukin-2-zusammensetzung.
DK129385A (da) * 1985-03-22 1986-09-23 Novo Industri As Peptider og fremstilling deraf
US4937085A (en) * 1986-08-15 1990-06-26 Agra-Research, Inc. Discoloration preventing food preservative and method
GB8806893D0 (en) * 1988-03-23 1988-04-27 Unilever Plc Cosmetic composition
KR900003362A (ko) * 1988-08-24 1990-03-26 전학제 유전공학기법을 이용한 인체 인슈린 유사체의 제조방법
JPH0341033A (ja) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd 安定なモチリン類含有製剤
US5227293A (en) 1989-08-29 1993-07-13 The General Hospital Corporation Fusion proteins, their preparation and use
IL95495A (en) 1989-08-29 1996-10-16 Hoechst Ag Fusion proteins their preparation and use
US5288931A (en) * 1991-12-06 1994-02-22 Genentech, Inc. Method for refolding insoluble, misfolded insulin-like growth factor-I into an active conformation
US5663304A (en) * 1993-08-20 1997-09-02 Genentech, Inc. Refolding of misfolded insulin-like growth factor-I
IL139335A (en) * 1994-01-03 2005-08-31 Genentech Inc Mpl ligand polypeptides, nucleic acids encoding them, vectors and host cells comprising such nucleic acids, processes for producing such polypeptides pharmaceutical compositions containing them and use thereof in the preparation of medicaments for treating thrombocytopenia
DE4405179A1 (de) * 1994-02-18 1995-08-24 Hoechst Ag Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
US6165981A (en) * 1995-03-07 2000-12-26 Dade Behring Inc. Stabilizing solutions for proteins and peptides
US5780431A (en) * 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form
DE19735711C2 (de) * 1997-08-18 2001-04-26 Aventis Pharma Gmbh Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken

Also Published As

Publication number Publication date
BRPI0012150B8 (pt) 2021-05-25
KR20020026515A (ko) 2002-04-10
EP1196447B1 (de) 2009-02-18
US6339061B1 (en) 2002-01-15
NO329429B1 (no) 2010-10-18
NO20016071L (no) 2001-12-12
CA2377794A1 (en) 2001-01-11
JP2003504313A (ja) 2003-02-04
HUP0202264A3 (en) 2005-01-28
AR024621A1 (es) 2002-10-16
HU228936B1 (en) 2013-06-28
KR100754235B1 (ko) 2007-09-03
HK1047115B (zh) 2006-02-24
ATE423137T1 (de) 2009-03-15
CA2377794C (en) 2011-12-06
PL353160A1 (en) 2003-10-20
US7514403B2 (en) 2009-04-07
WO2001002435A1 (de) 2001-01-11
BRPI0012150B1 (pt) 2016-06-14
NZ516372A (en) 2004-03-26
CN1357008A (zh) 2002-07-03
ES2321373T3 (es) 2009-06-05
AU768443B2 (en) 2003-12-11
ZA200110507B (en) 2002-07-24
EP1196447A1 (de) 2002-04-17
US6734164B2 (en) 2004-05-11
JP4555525B2 (ja) 2010-10-06
NO20016071D0 (no) 2001-12-12
CN1220703C (zh) 2005-09-28
IL147250A (en) 2010-02-17
IL147250A0 (en) 2002-08-14
MXPA01012836A (es) 2002-07-30
DE19930676A1 (de) 2001-01-18
DE50015562D1 (de) 2009-04-02
HK1047115A1 (en) 2003-02-07
US20020058623A1 (en) 2002-05-16
BR0012150A (pt) 2002-05-21
SI1196447T1 (sl) 2009-08-31
HUP0202264A2 (en) 2002-10-28
DE19930676B4 (de) 2006-01-19
DK1196447T3 (da) 2009-06-15
PL200145B1 (pl) 2008-12-31
US20040230038A1 (en) 2004-11-18
AU5816400A (en) 2001-01-22
PT1196447E (pt) 2009-04-20

Similar Documents

Publication Publication Date Title
EA200400241A1 (ru) Направленные к мишени мультимерные контрастные вещества, основанные на пептидах
EA200000789A1 (ru) N-[(замещенное пятичленное ди- или триазадиненасыщенное кольцо) карбонил] гуанидиновые производные для лечения ишемии
CY1113684T1 (el) Anti-mikρobiaka πεπτιδια που περιλαμβανουν μια αργινινη (arginine)- kai/ή λυσινη (lysine)- που περιεχουν υποκινητη
UY27630A1 (es) Péptidos macrocíclicos activos contrael virus de la hepatitis c.
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
EA200000920A1 (ru) Производные бициклических гидроксамовых кислот
EA200301289A1 (ru) Новые производные пиррола в качестве фармацевтических средств
ATE396984T1 (de) Gewinnung von delta-9 tetrahydrocannabinol
PE20110102A1 (es) Derivados de n-(2-oxo-2-pirrolidinil-1-il)etil-2-amino-acetamida como inhibidores de proteinas de apoptosis (iap)
CY1109050T1 (el) Μεθοδος σταθεροποιησης πρωτεϊνων σε συμπλοκα μιγματα κατα την αποθηκευση τους σε υδατικους διαλυτες
ES534195A0 (es) Procedimiento para preparar una solucion estable de proteina
CY1115918T1 (el) Συνθεσεις βασιζομενες επι διακλαδισμενης αλυσου αμινοξεων για βελτιωση της μυοκαρδιακης κοιλιακης λειτουργιας σε ασθενεις που υποφερουν απο διαβητη
DE60113533D1 (de) Derivate von beta-aminosäurenitrilen
EA200300705A1 (ru) Смеси соединения модафинила и циклодекстрина
EA200200492A1 (ru) Растворы, содержащие эпинастин
DE50213681D1 (de) Wässrige Lösung von Ascorbinsäure
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
EA200300450A1 (ru) Фармацевтические растворы соединений модафинила
ATE365801T1 (de) Modulierung durch il-tif/interleukin-21
DE602004026242D1 (de) Derivate von alkalischen Aminosäuren als Geliermitteln
PE20040703A1 (es) Derivados aldehido de polietilenglicol
DE60030266D1 (de) Pyrrolidincarbonylamin-enthaltende cyclische peptid-disulfide als antagonists von vcam-vla4
ITMI20032463A1 (it) Soluzione acquosa concentrata a base di ambroxolo
DE60232018D1 (de) 3-phenyl-2-arylalkylthiopropionsäure-derivate als selektive agonisten von ppar-alpha
DE60012508D1 (de) Aminosäuren mit polycyclischer struktur als pharmaka